Adicet Bio completes prula-cel last patient visit
Adicet Bio said the last patient visit for prula-cel is complete and topline SLE data is expected in September 2026. The company also said ADI-212 IND has cleared.
Adicet Bio completed the last patient visit for prula-cel and expects topline SLE data in September 2026.Key Highlights:Original SEC Filing: Adicet Bio, Inc. [ ACET ] - 8-K - Sep.
01, 2026This is an AI-powered summary.
It may contain inaccuracies.
Consider verifying important information with the s…